Valerianna K Amorosa

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Is it time to rethink the expanded-access programs for HIV infection?
    Valerianna Amorosa
    University of Pennsylvania, Philadelphia, PA 19104, USA
    J Infect Dis 196:974-7. 2007
  2. ncbi Imported Lassa fever, Pennsylvania, USA, 2010
    Valerianna Amorosa
    University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Emerg Infect Dis 16:1598-600. 2010
  3. ncbi New frontiers of HCV therapy in HIV/HCV co-infection
    Valerianna K Amorosa
    Department of Medicine, University of Pennsylvania, 8th Floor, Philadelphia VAMC, Philadelphia, PA 19104, USA
    Curr HIV/AIDS Rep 7:117-26. 2010
  4. ncbi Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    AIDS Behav 17:94-103. 2013
  5. ncbi Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study
    Vincent Lo Re
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Ann Intern Med 155:353-60. 2011
  6. ncbi Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity
    Ingi Lee
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 30:1266-74. 2011
  7. ncbi Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients
    Michelle DallaPiazza
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    BMC Infect Dis 10:116. 2010
  8. ncbi Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6073, USA
    Clin Liver Dis 12:587-609, ix. 2008
  9. ncbi Adherence to hepatitis C virus therapy and early virologic outcomes
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Dr, Philadelphia, PA 19104 6021, USA
    Clin Infect Dis 48:186-93. 2009
  10. ncbi The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients
    Valerianna K Amorosa
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Antivir Ther 15:91-9. 2010

Detail Information

Publications13

  1. ncbi Is it time to rethink the expanded-access programs for HIV infection?
    Valerianna Amorosa
    University of Pennsylvania, Philadelphia, PA 19104, USA
    J Infect Dis 196:974-7. 2007
    ....
  2. ncbi Imported Lassa fever, Pennsylvania, USA, 2010
    Valerianna Amorosa
    University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Emerg Infect Dis 16:1598-600. 2010
    ..The patient recovered with supportive therapy. No secondary cases occurred...
  3. ncbi New frontiers of HCV therapy in HIV/HCV co-infection
    Valerianna K Amorosa
    Department of Medicine, University of Pennsylvania, 8th Floor, Philadelphia VAMC, Philadelphia, PA 19104, USA
    Curr HIV/AIDS Rep 7:117-26. 2010
    ..This review discusses HCV treatments in development, with special attention to four agents being studied actively among HIV/HCV-co-infected persons...
  4. ncbi Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    AIDS Behav 17:94-103. 2013
    ..Among HIV/HCV patients, EVR and SVR increased with higher interferon and ribavirin adherence. Adherence to both antivirals declined over time, but more so for ribavirin...
  5. ncbi Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study
    Vincent Lo Re
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Ann Intern Med 155:353-60. 2011
    ..Adherence to therapy with pegylated interferon and ribavirin for hepatitis C virus (HCV) infection has been incompletely examined...
  6. ncbi Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity
    Ingi Lee
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 30:1266-74. 2011
    ..However, there have been few studies examining whether HCV infection reduces survival after heart transplantation...
  7. ncbi Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients
    Michelle DallaPiazza
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    BMC Infect Dis 10:116. 2010
    ..Since HIV-monoinfected patients do not routinely undergo liver biopsy, we evaluated the prevalence and risk factors of significant hepatic fibrosis in this group using the aspartate aminotransferase (AST)-to-platelet ratio index (APRI)...
  8. ncbi Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6073, USA
    Clin Liver Dis 12:587-609, ix. 2008
    ....
  9. ncbi Adherence to hepatitis C virus therapy and early virologic outcomes
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Dr, Philadelphia, PA 19104 6021, USA
    Clin Infect Dis 48:186-93. 2009
    ..We examined the relationship between adherence to pegylated interferon and ribavirin therapy, measured by pharmacy refill, and HCV suppression during the initial 12 weeks of therapy...
  10. ncbi The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients
    Valerianna K Amorosa
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Antivir Ther 15:91-9. 2010
    ..The aim of this study was to determine if use of abacavir, as well as other antiretrovirals, was associated with reduced response to pegylated interferon (PEG-IFN) plus ribavirin...
  11. ncbi A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia
    Valerianna Amorosa
    Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA 19104-6073, USA
    J Acquir Immune Defic Syndr 39:557-61. 2005
    ..Women, particularly those of African American race, are at high risk. Obesity might add to metabolic abnormalities associated with HIV or its treatment and contribute to morbidity, as patients with HIV live longer...
  12. ncbi Separate worlds set to collide: smallpox, vaccinia virus vaccination, and human immunodeficiency virus and acquired immunodeficiency syndrome
    Valerianna K Amorosa
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania and the Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania 19104-6073, USA
    Clin Infect Dis 37:426-32. 2003
    ....
  13. ncbi Bone disease and HIV infection
    Valerianna Amorosa
    Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Clin Infect Dis 42:108-14. 2006
    ....